Sir Winfried Bischoff

Dr GÖran Ando

Dr Ando was CEO of Celltech Group plc, UK, until 2004. He joined Celltech from Pharmacia, now Pfizer, US, where he was executive vice president and president of R&D with additional responsibilities for manufacturing, IT, business development and Mergers & Acquisitions (M&A) from 1995 to 2003.

From 1989 to 1995, Dr Ando was medical director, moving to deputy R&D director and then R&D director of Glaxo Group, UK. He was also a member of the Glaxo Group Executive Committee.

Dr Ando is a specialist in general medicine and a founding fellow of the American College of Rheumatology in the US. Dr Ando qualified as a medical doctor at Linköping Medical University, Sweden, in 1973 and as a specialist in general medicine at the same institution in 1978.

Board Mandates

Dr Ando is Chairman of the Board of Directors of Novo Nordisk A/S and Chairman of the Board of Directors of Symphogen A/S in Denmark.

Dr Ando also serves as Senior Advisor to Essex Woodlands Health Ventures Ltd, UK and is a member of the board at Novo A/S, Denmark, Molecular Partners AG, Switzerland and EUSA Pharma, UK.


In 2002 Dr Ando was awarded an Honorary Doctorate in Medicine from the Karolinska Institute in Stockholm.

Download this bio as a pdf file

chairman mentors